Compare AMPG & BSEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMPG | BSEM |
|---|---|---|
| Founded | 2002 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.0M | 76.9M |
| IPO Year | 2012 | 2026 |
| Metric | AMPG | BSEM |
|---|---|---|
| Price | $2.48 | $1.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 693.2K | 155.2K |
| Earning Date | 11-17-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 69.44 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $25,195,930.00 | N/A |
| Revenue This Year | $44.47 | N/A |
| Revenue Next Year | $64.84 | $87.68 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 164.99 | N/A |
| 52 Week Low | $1.64 | $1.04 |
| 52 Week High | $10.11 | $5.44 |
| Indicator | AMPG | BSEM |
|---|---|---|
| Relative Strength Index (RSI) | 37.07 | 23.28 |
| Support Level | $2.47 | N/A |
| Resistance Level | $2.83 | $4.65 |
| Average True Range (ATR) | 0.16 | 0.24 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 32.33 | 8.73 |
AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. It operates in two segments: the manufacturing and engineering segment. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.
BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.